Financials

  • Market Capitalization 70.85 M
  • Employee 17
  • Founded 2009
  • CEO N/A
  • Website www.renovorx.com
  • Headquarter Delaware, United States
  • FIGI BBG005XWWZK6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.63
Rapporto prezzo/fatturato
26.43

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4122
PLRX
Pliant Therapeutics, Inc. - Common Stock
1.15 USD-0.86%0.00%+6.48%-29.01%71.21 M USD
4127
SPRO
Spero Therapeutics, Inc. - Common Stock
1.21 USD-0.82%-2.42%+0.83%-39.80%70.46 M USD
4131
MNOV
MediciNova, Inc. - Common Stock
1.44 USD+1.41%+3.60%+11.63%+7.46%70.88 M USD
4132
XBIT
XBiotech Inc. - Common Stock
2.30 USD0.00%+0.44%-0.86%-32.15%70.12 M USD

Notizie